- Researchers find potential poliovirus treatment in a human monoclonal antibody, 9H2. It binds within the poliovirus receptor-binding site to neutralize all three serotypes, making it an attractive antiviral candidate for future development. https://www.nature.com/articles/s41467-023-41052-9 3 comments science